Company: VERA
Filing Date: 2025-12-10
Form Type: 424B5
Source: 0001193125-25-314244
Chunk: 26

Company: Vera Therapeutics, Inc.
Filing Date: 2025-12-10
Form: 424B5
Chunk 26
---
 provided, that in the event that such change of control is not completed, the lock-up securities owned by the lock-up party shall remain subject to the restrictions described herein; (viii) transfers of the
lock-up securities arising as a result of the termination of employment of the lock-up party to us pursuant to agreements that are in effect as of the date of the
underwriting agreement for this offering and disclosed in this prospectus supplement, under which we have the option to repurchase such lock-up securities or a right of first refusal with respect to transfers
of such lock-up securities; or (ix) transfers pursuant to a 10b5-1 Plan that is in effect as of the date of the lock-up
agreement; provided, however, that in the case of any transfer during the restricted period, if the lock-up party is required to file a report under Section 16 of the Exchange Act, the lock-up party shall include a statement in such report to the effect that such transfer is being made pursuant to a previously adopted 10b5-1 Plan.

We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act.

Our Class A common stock is listed on the Nasdaq Global Market under the symbol “VERA.”

In connection with this offering, the underwriters may engage in stabilizing transactions, which involves making bids for, purchasing and selling shares of Class A
common stock in the open market for the purpose of preventing or retarding a decline in the market price of the Class A common stock while this offering is in progress. These stabilizing transactions may include making short sales of
Class A common stock, which involves the sale by the underwriters of a greater number of shares of Class A common stock than they are required to purchase in this offering, and purchasing shares of Class A common stock on the open
market to cover positions created by short sales. Short sales may be “covered” shorts, which are short positions in an amount not greater than the underwriters’ option to purchase additional shares referred to above, or may be
“naked” shorts, which are short positions in excess of that amount. The underwriters may close out any covered short position either by exercising their option to purchase additional shares, in whole or in part, or by purchasing shares
in the open market. In making this determination, the underwriters will consider, among other things, the price of shares available for purchase in the open market compared to the price at which the underwriters may